Tci Wealth Advisors, Inc. Cara Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$4.89 - $12.27 $3,198 - $8,024	654 Added 872.0%	729 $3,000
Q2 2022 Jul 19, 2022	SELL	$7.45 - $13.84 $1,758 - $3,266	-236 Reduced 75.88%	75 $1,000
Q3 2021 Oct 29, 2021	BUY	$11.55 - $16.06 $2,725 - $3,790	236 Added 314.67%	311 $5,000
Q2 2021 Aug 02, 2021	SELL	$12.38 - $29.19 $1,250 - $2,948	-101 Reduced 57.39%	75 $1,000
Q1 2021 Apr 29, 2021	BUY	$15.07 - $21.71 $15 - $21	1 Added 0.57%	176 $4,000
Q3 2017 Oct 24, 2017	BUY	$12.6 - $16.34 $1,260 - $1,634	100 Added 133.33%	175 $2,000
Q2 2017 Aug 10, 2017	BUY	N/A	75	75 $1,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.